- Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT
- Cellectis présente des données de recherche d’une nouvelle cellule CAR T universelle au congrès annuel de l’ASGCT
- Cellectis publie ses résultats financiers du premier trimestre 2022
- Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
- Monthly information on share capital and company voting rights
- Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
- Cellectis annonce ses résultats financiers pour le premier trimestre 2022
- Cellectis to Report First Quarter 2022 Financial Results
- Calyxt, Inc., Cellectis’ Majority-Owned Subsidiary, Reports Its First Quarter 2022 Financial Results
- Cellectis Publishes Two Articles in Nature Communications Providing Strong Preclinical Validation of UCART123 to Treat AML and BPDCN
More ▼
Key statistics
As of last trade, Cellectis SA (ZVAA:BER) traded at 3.44, 32.31% above the 52 week low of 2.60 set on May 12, 2022.
52-week range
Markit short selling activity
Open | 3.44 |
---|---|
High | 3.44 |
Low | 3.44 |
Bid | 3.38 |
Offer | 3.70 |
Previous close | 3.56 |
Average volume | 0.00 |
---|---|
Shares outstanding | 45.48m |
Free float | 45.48m |
P/E (TTM) | -- |
Market cap | 170.42m USD |
EPS (TTM) | -2.97 USD |
Data delayed at least 15 minutes, as of May 23 2022 07:01 BST.
More ▼